Nav: Home

Nebraska leads $11 million study to develop radiation exposure drugs

January 14, 2019

The U.S. Department of Defense has turned to the University of Nebraska to jumpstart the development of drug therapies to protect military service members from the effects of radiation exposure.

In an environment where for-profit pharmaceutical companies are often reluctant to embark upon financially risky drug discovery efforts, the unique four-pronged partnership established by the university and the Department of Defense could shorten the U.S. military's wait for drugs that prevent and counteract the effects of radiation exposure.

"It's an exciting collaboration among the federal government, our state university and two of its premier research campuses -- University of Nebraska Medical Center and the University of Nebraska-Lincoln -- and consultants from private pharma who are Nebraska alumni," said David Berkowitz, professor of chemistry.

This team operates under the auspices of the university's National Strategic Research Institute, one of 13 university-affiliated research centers. Nebraska has the lone research center entrusted by the military to work on chemical, biological, radiological and nuclear threats.

"This research represents the broad capacity of the University of Nebraska and its alumni consultants to tackle potentially hazardous radiation exposures around the world," said Lt. Gen. (Ret.) Robert Hinson, founding executive director of the National Strategic Research Initiative.

The University of Nebraska project for the Defense Health Agency, and in collaboration with Armed Forces Radiobiology Research Institute, has reached a second increment -- potentially awarding nearly $11 million in federal funding over the next five years. Nebraska researchers will look for therapeutics candidates the U.S. military would need to protect troops from radiation in case of exposure, as in a nuclear accident or a nuclear weapons incident.

Leveraging the full, collaborative strength of a united university system -- multiple campuses, a network of successful alums -- directed by the Department of Defense, is something new for the university.

"I've never been involved with anything like that before," Berkowitz said. "This team came together as a joint vision between the team leadership and our (Department of Defense) funders and it's pretty unusual across the country to see such a public-private-government partnership."

In fact, the university hopes this opens the door to continued partnership with private pharma in the longer term, through identifying and developing therapeutic candidates that have dual-purposing potential, Berkowitz said. Berkowitz is co-primary investigator of the project, with Ken Bayles, professor of pathology and microbiology at UNMC.

Bayles said if private pharmaceutical companies are leaving a gap, the University of Nebraska is eager to step in.

"We've pitched this concept to develop a virtual pharmaceutical company, a drug development pipeline that would coordinate the activities of all the expertise we have across all of our campuses and develop capabilities to move molecules forward for drug development," he said.

Handfuls of NU's top scientists will work on medicinal chemistry, metabolomics and bioinformatics in order to move potential drug candidates toward clinical trials. "We'll be coordinating all of these aspects like a pharmaceutical company does," Bayles said. "If we do it right, this pipeline concept is an opportunity to build the economy in Nebraska, build the pharmaceutical industry in Nebraska."

Berkowitz said the new multi-pronged, multi-campus team is complex, but, "it's working pretty well."

"We are extremely proud to be affiliated with this research and the impact it can have for the Department of Defense, Defense Health Agency and other agencies as well," Lt. Gen. Hinson said.

Consultants from pharmaceutical industry will advise Nebraska scientists on the drug development effort.

Collaborators include the following University of Nebraska scientists, who bring key expertise to the project to establish a drug development pipeline that could speed the process of developing new drugs at the Armed Forces Radiobiology Research Institute to counteract the effects of radiation exposure:

* Samuel Cohen, UNMC, toxicology. * Patrick Dussault, UNL, synthetic chemistry. * Babu Guda, UNMC, bioinformatics. * Tomas Helikar, UNL, computational systems biology. * DJ Murry, UNMC, pharmacokinetics and pharmacogentics. * Rebecca Oberley-Deegan, UNMC, radiation therapeutics. * Robert Powers, UNL, metabolomics.

Additionally, multiple University of Nebraska alums, all doctoral scientists, with current or former experience in private pharma, also are involved. This experienced consultant team includes Eugene Cordes of Philadelphia (honorary degree, UNL, 2009), Norton Peet, Holland, Mich. (Ph.D., UNL, chemistry, 1970), Kevin Woller, Antioch, Ill. (Ph.D., UNL, chemistry , 1996), Chad Briscoe, Overland Park, Kan. (Ph.D., UNL, chemistry, 2009), Ryan Hartung, Tuscon, Ariz. (B.S., UNL, chemistry, 2000).

"They are appreciative of the opportunity to give back to their home institution," said Berkowitz. "They really like the idea of the Lincoln and Omaha campuses collaborating. They really like working for the DoD. There is a patriotic aspect of helping the country and protecting our troops using the tools of biomedical science.

"That's something that has made this project special for all of us."

University of Nebraska-Lincoln

Related Radiation Articles:

Cloudy with a chance of radiation: NASA studies simulated radiation
NASA's Human Research Program (HRP) is simulating space radiation on Earth following upgrades to the NASA Space Radiation Laboratory (NSRL) at the US Department of Energy's Brookhaven National Laboratory.
Visualizing nuclear radiation
Extraordinary decontamination efforts are underway in areas affected by the 2011 nuclear accidents in Japan.
Measuring radiation damage on the fly
Researchers at MIT and elsewhere have found a new way to measure radiation damage in materials, quickly, cheaply and continuously, using transient grating spectroscopy.
Radiation that knocks electrons out and down, one after another
Researchers at Japan's Tohoku University are investigating novel ways by which electrons are knocked out of matter.
Novel advancements in radiation tolerance of HEMTs
When it comes to putting technology in space, size and mass are prime considerations.
Radiation-guided nanoparticles zero in on metastatic cancer
Zap a tumor with radiation to trigger expression of a molecule, then attack that molecule with a drug-loaded nanoparticle.
Graphene is both transparent and opaque to radiation
A microchip that filters out unwanted radiation with the help of graphene has been developed by scientists from the EPFL and tested by researchers of the University of Geneva (UNIGE).
Radiation causes blindness in wild animals in Chernobyl
This year marks 30 years since the Chernobyl nuclear accident.
No proof that radiation from X rays and CT scans causes cancer
The widespread belief that radiation from X rays, CT scans and other medical imaging can cause cancer is based on an unproven, decades-old theoretical model, according to a study published in the American Journal of Clinical Oncology.
Some radiation okay for expectant mother and fetus
During pregnancy, approximately 5 to 8 percent of women sustain traumatic injuries, including fractures and muscle tears.

Related Radiation Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Changing The World
What does it take to change the world for the better? This hour, TED speakers explore ideas on activism—what motivates it, why it matters, and how each of us can make a difference. Guests include civil rights activist Ruby Sales, labor leader and civil rights activist Dolores Huerta, author Jeremy Heimans, "craftivist" Sarah Corbett, and designer and futurist Angela Oguntala.
Now Playing: Science for the People

#521 The Curious Life of Krill
Krill may be one of the most abundant forms of life on our planet... but it turns out we don't know that much about them. For a create that underpins a massive ocean ecosystem and lives in our oceans in massive numbers, they're surprisingly difficult to study. We sit down and shine some light on these underappreciated crustaceans with Stephen Nicol, Adjunct Professor at the University of Tasmania, Scientific Advisor to the Association of Responsible Krill Harvesting Companies, and author of the book "The Curious Life of Krill: A Conservation Story from the Bottom of the World".